IS6582A - Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka - Google Patents

Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka

Info

Publication number: IS6582A
Authority: IS; Iceland
Prior art keywords: blood cell; cell receptors; formulation peptide; peptide; formulation
Prior art date: 2000-04-25

Application number

IS6582A

Other languages

English (en)

Inventor

Naranda Tatjana

Olsson Lennart

Original Assignee

Pliva, Farmaceutska Industrija, Dionicko Drustvo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-25

Filing date

2002-10-14

Publication date

2002-10-14

2002-10-14 Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo

2002-10-14 Publication of IS6582A publication Critical patent/IS6582A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)

IS6582A 2000-04-25 2002-10-14 Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka IS6582A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00108075A EP1149906A1 (en)	2000-04-25	2000-04-25	Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en)	2000-04-25	2001-04-23	Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number	Publication Date
IS6582A true IS6582A (is)	2002-10-14

Family

ID=8168467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6582A IS6582A (is)	2000-04-25	2002-10-14	Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka

Country Status (24)

Country	Link
US (1)	US20030181659A1 (is)
EP (2)	EP1149906A1 (is)
JP (1)	JP2003530867A (is)
KR (1)	KR20030009450A (is)
CN (1)	CN1426467A (is)
AR (1)	AR030278A1 (is)
AU (2)	AU2001267366B9 (is)
BG (1)	BG107214A (is)
BR (1)	BR0110383A (is)
CA (1)	CA2407167A1 (is)
CZ (1)	CZ20023517A3 (is)
EA (1)	EA006423B1 (is)
EE (1)	EE200200610A (is)
GE (1)	GEP20063763B (is)
HU (1)	HUP0300559A3 (is)
IL (1)	IL152204A0 (is)
IS (1)	IS6582A (is)
MX (1)	MXPA02010458A (is)
NO (1)	NO20025114L (is)
PL (1)	PL358304A1 (is)
SK (1)	SK15262002A3 (is)
WO (1)	WO2001080873A2 (is)
YU (1)	YU79202A (is)
ZA (1)	ZA200208662B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003039476A2 (en) *	2001-11-07	2003-05-15	Millennium Pharmaceuticals, Inc.	Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en)	2001-12-21	2011-04-12	Ferrosan Medical Devices A/S	Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
CA2499625A1 (en) *	2002-09-18	2004-04-01	Ortho-Mcneil Pharmaceutical, Inc.	Methods of increasing platelet and hematopoietic stem cell production
PL377477A1 (pl)	2002-12-11	2006-02-06	Ferrosan A/S	Materiały na bazie żelatyny jako waciki
CN1849141A (zh) *	2003-05-12	2006-10-18	阿费麦克斯公司	用于聚(乙二醇)修饰的肽的间隔臂部分
DE602004028725D1 (de) *	2003-05-12	2010-09-30	Affymax Inc	Neue poly(ethylenglycol) modifizierte erythropoietinagonisten und deren verwendungen
JP2005187435A (ja) *	2003-12-26	2005-07-14	Otsuka Chemical Co Ltd	血小板産生促進組成物
US7923031B2 (en)	2004-01-30	2011-04-12	Ferrosan Medical Devices A/S	Haemostatic sprays and compositions
CN101001649B (zh)	2004-07-09	2011-08-31	弗罗桑医疗设备公司	包括透明质酸的止血组合物及其制备方法
US20090004673A1 (en) *	2006-01-31	2009-01-01	Mitsubishi Kagaku Iatron, Inc.	Method for Determining Condition of Disseminated Intravascular Coagulation
WO2009109194A2 (en)	2008-02-29	2009-09-11	Ferrosan A/S	Device for promotion of hemostasis and/or wound healing
SG195007A1 (en) *	2011-05-13	2013-12-30	Univ Tokyo	Polynucleated megakaryocytic cell and method for manufacturing platelets
CN104159527B (zh)	2012-03-06	2017-04-12	弗罗桑医疗设备公司	包含止血糊剂的压力容器
BR112014030962A2 (pt)	2012-06-12	2017-06-27	Ferrosan Medical Devices As	métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
WO2014202760A2 (en)	2013-06-21	2014-12-24	Ferrosan Medical Devices A/S	Vacuum expanded dry composition and syringe for retaining same
BR112016013322B1 (pt)	2013-12-11	2020-07-21	Ferrosan Medical Devices A/S	métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt)	2014-10-13	2021-03-02	Ferrosan Medical Devices A/S	método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
EP3237041B1 (en)	2014-12-24	2020-01-29	Ferrosan Medical Devices A/S	Syringe for retaining and mixing first and second substances
WO2017005590A1 (en)	2015-07-03	2017-01-12	Ferrosan Medical Devices A/S	Syringe for mixing two components and for retaining a vacuum in a storage condition
AU2019266529B2 (en)	2018-05-09	2024-05-23	Ethicon Inc.	Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5498599A (en) *	1994-01-21	1996-03-12	Amgen Inc.	Methods for stimulating platelet production
YU34196A (sh) *	1995-06-07	1999-03-04	Glaxo Group Limited	Peptidi i jedinjenja koja se vezuju za receptor
US6342220B1 (en) *	1997-08-25	2002-01-29	Genentech, Inc.	Agonist antibodies
EP1064015A2 (en) *	1998-02-24	2001-01-03	Receptron, Inc.	Receptor derived peptides as modulators of receptor activity

2000
- 2000-04-25 EP EP00108075A patent/EP1149906A1/en not_active Ceased
2001
- 2001-04-23 US US10/258,565 patent/US20030181659A1/en not_active Abandoned
- 2001-04-23 AU AU2001267366A patent/AU2001267366B9/en not_active Ceased
- 2001-04-23 KR KR1020027014262A patent/KR20030009450A/ko not_active Ceased
- 2001-04-23 MX MXPA02010458A patent/MXPA02010458A/es unknown
- 2001-04-23 BR BR0110383-0A patent/BR0110383A/pt not_active IP Right Cessation
- 2001-04-23 YU YU79202A patent/YU79202A/sh unknown
- 2001-04-23 WO PCT/EP2001/004553 patent/WO2001080873A2/en not_active Ceased
- 2001-04-23 EA EA200201138A patent/EA006423B1/ru not_active IP Right Cessation
- 2001-04-23 EE EEP200200610A patent/EE200200610A/xx unknown
- 2001-04-23 IL IL15220401A patent/IL152204A0/xx unknown
- 2001-04-23 CN CN01808567A patent/CN1426467A/zh active Pending
- 2001-04-23 PL PL01358304A patent/PL358304A1/xx unknown
- 2001-04-23 AU AU6736601A patent/AU6736601A/xx active Pending
- 2001-04-23 SK SK1526-2002A patent/SK15262002A3/sk unknown
- 2001-04-23 CZ CZ20023517A patent/CZ20023517A3/cs unknown
- 2001-04-23 HU HU0300559A patent/HUP0300559A3/hu unknown
- 2001-04-23 CA CA002407167A patent/CA2407167A1/en not_active Abandoned
- 2001-04-23 JP JP2001577972A patent/JP2003530867A/ja active Pending
- 2001-04-23 GE GE4988A patent/GEP20063763B/en unknown
- 2001-04-23 EP EP01945029A patent/EP1278849A2/en not_active Withdrawn
- 2001-04-25 AR ARP010101924A patent/AR030278A1/es unknown
2002
- 2002-10-14 IS IS6582A patent/IS6582A/is unknown
- 2002-10-23 BG BG107214A patent/BG107214A/bg unknown
- 2002-10-24 NO NO20025114A patent/NO20025114L/no not_active Application Discontinuation
- 2002-10-25 ZA ZA200208662A patent/ZA200208662B/xx unknown

Also Published As

Publication number	Publication date
AU2001267366B2 (en)	2005-06-30
HUP0300559A3 (en)	2005-09-28
SK15262002A3 (sk)	2003-05-02
GEP20063763B (en)	2006-03-10
WO2001080873A3 (en)	2002-01-31
BG107214A (bg)	2003-11-28
WO2001080873A2 (en)	2001-11-01
IL152204A0 (en)	2003-05-29
EA006423B1 (ru)	2005-12-29
EP1278849A2 (en)	2003-01-29
MXPA02010458A (es)	2003-06-06
JP2003530867A (ja)	2003-10-21
NO20025114L (no)	2002-12-18
CN1426467A (zh)	2003-06-25
PL358304A1 (en)	2004-08-09
CA2407167A1 (en)	2001-11-01
KR20030009450A (ko)	2003-01-29
NO20025114D0 (no)	2002-10-24
AR030278A1 (es)	2003-08-20
YU79202A (sh)	2006-01-16
AU2001267366B9 (en)	2005-07-14
CZ20023517A3 (cs)	2003-10-15
EA200201138A1 (ru)	2003-06-26
AU6736601A (en)	2001-11-07
EP1149906A1 (en)	2001-10-31
HUP0300559A2 (hu)	2003-06-28
ZA200208662B (en)	2003-10-27
EE200200610A (et)	2004-08-16
US20030181659A1 (en)	2003-09-25
BR0110383A (pt)	2003-01-21

Publication	Publication Date	Title
IS6582A (is)	2002-10-14	Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
ATE431145T1 (de)	2009-05-15	Missbrauchssichere orale opioid-agonist zubereitungen
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
NO20032101D0 (no)	2003-05-09	Apoliprotein analoger
ATE392890T1 (de)	2008-05-15	Hydrogel-gesteuerte dosierungsform
DK1189853T3 (da)	2009-02-23	Betonformulering
DE50015294D1 (de)	2008-09-18	Mikrotom
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
ID29336A (id)	2001-08-23	Zat perekat
IS7571A (is)	2004-11-29	Ný lífeðlisfræðilega virk efni
DE60102651D1 (de)	2004-05-13	Spannungsmessgerät
ATE263487T1 (de)	2004-04-15	Flüssige formulierungen
NO20020151D0 (no)	2002-01-11	Veksthormonformuleringer
DE60122873D1 (de)	2006-10-19	Therapeutische porenbildende peptide
EP1171152A4 (en)	2002-09-25	VMIP-II PEPTIDE ANTAGONISTS OF CXCR4
DE50009946D1 (de)	2005-05-04	Schädlingsbekämpfungsmittel/depsipeptide
NO990937D0 (no)	1999-02-26	Kunstig rev
DE60104126D1 (de)	2004-08-05	Fungizide formulierung
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
EP1159288A4 (en)	2005-06-01	ALPHA-CONOTOXIN PEPTIDES
DE60012953D1 (de)	2004-09-16	3-amino-2-phenylpiperidinderivate als substanz p antagonisten
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
IT250089Y1 (it)	2003-07-07	Guanto per uso cosmetico
NO20041291D0 (no)	2004-03-26	Medisinske preparater som inneholder angiotensin II-reseptorantagonist